Drug Trial Radar · NCT02337062
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Last checked: Nov 20, 2026Latest source record: Mar 20, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,147
Actual
Start
Feb 2015
Primary completion
Sep 2015
Study completion Sep 2015
Sponsor
- Lead sponsor
- Acacia Pharma LtdIndustry
- Sponsor type
- Industry
- First posted
- Jan 13, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A comparison of the efficacy of APD421 and placebo when combined with a standard anti-emetic in the prevention of PONV in patients at high risk of Post-operative Nausea and Vomiting (PONV).
Conditions
- PONV
Interventions
APD421Drug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Complete ResponseTime frame: 24 hours after the end of surgery
Locations
25 sites in 3 countries. Site status is shown where the registry gives one.
Helen Keller Hospital
Sheffield, Alabama
UCSF School of Medicine
San Francisco, California
Jackson Memorial Hospital
Miami, Florida
University of Kansas Medical Center
Kansas City, Kansas
Brigham and Women's Hospital
Boston, Massachusetts
Albany Medical Center Hospital
Albany, New York
Stony Brook Medicine
Stony Brook, New York
Duke University Medical Center
Durham, North Carolina
Wake Forest University School of Medicine
Winston-Salem, North Carolina
Cleveland Clinic
Cleveland, Ohio
Ohio State University
Columbus, Ohio
First Street Surgical Center
Bellaire, Texas
Victory Medical Center Houston
Houston, Texas
Memorial Hermann-Memorial City Hospital
Houston, Texas
University Hospital
Besançon, France
Centre Hospitalier Lyon-Sud
Lyon, France
Centre Hospitalier de Mulhouse
Mulhouse, France
Hopital Foch
Paris, France
CHU de Hautepierre
Strasbourg, France
HELIOS Klinikum Aue
Aue, Germany
Universitätsklinikum Bonn
Bonn, Germany
Klinikum Ludwigshafen
Ludwigshafen, Germany
Universitätsmedizin Mainz
Mainz, Germany
Philipps University
Marburg, Germany
University Hospitals of Würzburg
Würzburg, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.